| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Comprehensive Methodology to Systematically Identify Drug Hypersensitivity and Anaphylactic Reactions in Clinical Trial Databases
|
Xavier, Hugo
|
|
|
|
5 |
p. 335-345
|
artikel
|
| 2 |
Are the Current Processes and Regulations Fit for Purpose to Deliver Novel Therapies During Pandemics? A Perspective on COVID-19 from the UK
|
Jandu, Rajmeet
|
|
|
|
5 |
p. 275-278
|
artikel
|
| 3 |
Association of Clinical Research Professionals (ACRP) 2023 Annual Conference
|
Pochon, Sue
|
|
|
|
5 |
p. 395-397
|
artikel
|
| 4 |
A Survey of Industry Perceptions of Facilitated Regulatory Pathways in Drug Development in Australia
|
Yoffe, Alina
|
|
|
|
5 |
p. 385-394
|
artikel
|
| 5 |
Authors’ Reply to Santos et al.: “Excipients in Neonatal Medicinal Products: Never Prescribed, Commonly Administered”
|
Valeur, Kristine Svinning
|
|
|
|
5 |
p. 361-362
|
artikel
|
| 6 |
Comment on: “Excipients in Neonatal Medicinal Products: Never Prescribed, Commonly Administered”
|
dos Santos, Carlos E. Matos
|
|
|
|
5 |
p. 359-360
|
artikel
|
| 7 |
Correction to: The Risk Evaluation and Mitigation Strategy (REMS) Public Dashboard: Improving Transparency of Regulatory Activities
|
Toyserkani, Gita A.
|
|
|
|
5 |
p. 355
|
artikel
|
| 8 |
Developing Medical Affairs Leaders Who Create the Future
|
Bedenkov, Alexander
|
|
|
|
5 |
p. 301-307
|
artikel
|
| 9 |
Electronic Reporting Systems in Pharmacovigilance: The Implementation of VigiFlow in Brazil
|
Vogler, Marcelo
|
|
|
|
5 |
p. 327-334
|
artikel
|
| 10 |
Forum
|
|
|
|
|
5 |
p. 347-355
|
artikel
|
| 11 |
Forum
|
|
|
|
|
5 |
p. 365-378
|
artikel
|
| 12 |
Forum
|
|
|
|
|
5 |
p. 297-310
|
artikel
|
| 13 |
How the Global COVID-19 Pandemic Brought Drug and Vaccine Development into the Public Mainstream
|
Witek, Theodore J.
|
|
|
|
5 |
p. 287-295
|
artikel
|
| 14 |
ICD-11: Impact on Traditional Chinese Medicine and World Healthcare Systems
|
Lam, Wai Ching
|
|
|
|
5 |
p. 373-377
|
artikel
|
| 15 |
Increasing Efficiency and Cost-Effectiveness by Automating the Authoring of the Development Safety Update Report
|
Pianka, Krystle
|
|
|
|
5 |
p. 297-305
|
artikel
|
| 16 |
Journal Watch
|
|
|
|
|
5 |
p. 317-332
|
artikel
|
| 17 |
Journal Watch
|
|
|
|
|
5 |
p. 321-334
|
artikel
|
| 18 |
Journal Watch
|
|
|
|
|
5 |
p. 325-334
|
artikel
|
| 19 |
Leveraging Case Narratives to Enhance Patient Age Ascertainment from Adverse Event Reports
|
Pham, Phuong
|
|
|
|
5 |
p. 307-316
|
artikel
|
| 20 |
Major Pharmaceutical Conferences and Courses
|
|
|
|
|
5 |
p. 357-358
|
artikel
|
| 21 |
Major Pharmaceutical Conferences and Courses
|
|
|
|
|
5 |
p. 297-301
|
artikel
|
| 22 |
Major Pharmaceutical Conferences and Courses: December 2022 to January 2023
|
|
|
|
|
5 |
p. 319-321
|
artikel
|
| 23 |
Major Pharmaceutical Conferences and Courses: December 2021 to January 2022
|
|
|
|
|
5 |
p. 317-318
|
artikel
|
| 24 |
Major Pharmaceutical Conferences and Courses: December 2023 to January 2024
|
|
|
|
|
5 |
p. 399-400
|
artikel
|
| 25 |
Medical Research Charities and Biopharmaceutical Companies as Partners in Patient-Centred R&D
|
Flatau, Tina
|
|
|
|
5 |
p. 279-286
|
artikel
|
| 26 |
Paediatric Oncology at the Crossroads: A Call for Change
|
Rose, Klaus
|
|
|
|
5 |
p. 297-300
|
artikel
|
| 27 |
Patient Experience Information: Streamlining and Harmonizing the Collection of Patient Preference and Patient-Reported Outcomes Data
|
Reaney, Matthew
|
|
|
|
5 |
p. 309-314
|
artikel
|
| 28 |
Perspectives on Adherence to Glaucoma Medical Therapy in Brazilian Patients
|
da Costa Andrade, Julia
|
|
|
|
5 |
p. 377-384
|
artikel
|
| 29 |
Pricing and Market Access Challenges in the Era of One-Time Administration Cell and Gene Therapies
|
Sabatini, Marco T.
|
|
|
|
5 |
p. 265-274
|
artikel
|
| 30 |
Proposal of Standard for Medical Science Liaison (MSL) Profession in Japan: A Viewpoint from the Japanese Association of Pharmaceutical Medicine (JAPhMed)
|
Tomiyasu, Michiko
|
|
|
|
5 |
p. 315-326
|
artikel
|
| 31 |
Recognition of Coroners’ Concerns to Prevent Future Deaths from Medicines: A Systematic Review
|
Ferner, Robin E.
|
|
|
|
5 |
p. 357-363
|
artikel
|
| 32 |
The Cost of Biotech Innovation: Exploring Research and Development Costs of Cell and Gene Therapies
|
Sabatini, Marco T.
|
|
|
|
5 |
p. 365-375
|
artikel
|
| 33 |
The 7+ Habits of Highly Effective Medical Directors
|
Bedenkov, Alexander
|
|
|
|
5 |
p. 267-279
|
artikel
|
| 34 |
The Randomised Controlled Trial at the Intersection of Research Ethics and Innovation
|
Callréus, Torbjörn
|
|
|
|
5 |
p. 287-293
|
artikel
|
| 35 |
The Risk Evaluation and Mitigation Strategy (REMS) Public Dashboard: Improving Transparency of Regulatory Activities
|
Toyserkani, Gita A.
|
|
|
|
5 |
p. 349-353
|
artikel
|
| 36 |
The Use of Artificial Intelligence in Pharmacovigilance: A Systematic Review of the Literature
|
Salas, Maribel
|
|
|
|
5 |
p. 295-306
|
artikel
|
| 37 |
Utilizing Deep Learning for Detecting Adverse Drug Events in Structured and Unstructured Regulatory Drug Data Sets
|
Knisely, Benjamin M.
|
|
|
|
5 |
p. 307-317
|
artikel
|
| 38 |
Where is European Regulation 536/2014 Taking Us?
|
Fox, Anthony W.
|
|
|
|
5 |
p. 343-347
|
artikel
|
| 39 |
Why Does the Precautionary Principle Suffice for Blood Regulation?
|
Seifner, Alexandra
|
|
|
|
5 |
p. 281-286
|
artikel
|
Tijdschrift beschrijving